15 results
8-K
EX-99.1
CTKB
Cytek BioSciences Inc
19 Mar 24
Cytek® Biosciences Names William McCombe Chief Financial Officer
5:00pm
, and transformational leadership skills, uniquely positions him to drive our corporate objectives.” stated Dr. Wenbin Jiang, Cytek’s Chairman and CEO
8-K
EX-99.1
CTKB
Cytek BioSciences Inc
1 Mar 24
Cytek Biosciences Reports Fourth Quarter and Full Year 2023 Financial Results and Provides 2024 Outlook
6:06am
strategic growth and delivering long-term profitability. Cytek remains on the forefront of innovation and industry leadership, and we are excited
8-K
EX-99.2
CTKB
Cytek BioSciences Inc
1 Mar 24
Cytek Biosciences Reports Fourth Quarter and Full Year 2023 Financial Results and Provides 2024 Outlook
6:06am
of innovation and the industry leadership and we are excited for our bright future ahead.
With that, I will now turn the call over to Patrik for more
8-K
EX-99.1
v89nh2x
28 Nov 23
Regulation FD Disclosure
7:00am
DEF 14A
fwmvdb
14 Apr 22
Definitive proxy
4:01pm
10-K
4yhyzb
17 Mar 22
Annual report
4:38pm
424B4
qpmj3zk x64q
23 Jul 21
Prospectus supplement with pricing info
4:12pm
S-1/A
u76p24mn
13 Jul 21
IPO registration (amended)
9:03pm
S-1
6o839z0eg1
2 Jul 21
IPO registration
4:34pm
DRS/A
cl1x9o7n8t179
14 Jun 21
Draft registration statement (amended)
12:00am
DRS
0xz0 tphn
22 Apr 21
Draft registration statement
12:00am
- Prev
- 1
- Next